Geneva Health Files

Geneva Health Files

Share this post

Geneva Health Files
Geneva Health Files
Views from a vaccine manufacturer: Q&A - Abdul Muktadir, Incepta Pharmaceuticals; Pandemic Treaty Action

Views from a vaccine manufacturer: Q&A - Abdul Muktadir, Incepta Pharmaceuticals; Pandemic Treaty Action

Newsletter Edition #43 [The Weekly Primer]

Priti Patnaik's avatar
Priti Patnaik
Mar 30, 2021
∙ Paid

Share this post

Geneva Health Files
Geneva Health Files
Views from a vaccine manufacturer: Q&A - Abdul Muktadir, Incepta Pharmaceuticals; Pandemic Treaty Action
Share

Share Geneva Health Files

Hi,

Far away from Geneva, some developing countries are vying to become the next big vaccine manufacturing powerhouse. With India facing surging infections caused by SARS-CoV-2 and its variants, the pressure on Indian manufacturers to retain vaccine doses for India and the neighborhood will only increase, notwithstanding contractual commitments with West…

Keep reading with a 7-day free trial

Subscribe to Geneva Health Files to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Priti Patnaik
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share